Data Availability
Disclosure of our MedWAS data, though de-identified and aggregated, is subject to approval and oversight by the Office of Contracts Management (OCM) at VUMC, as our source data is derived from protected health information (PHI), and some drug-disease pairs are individually identifiable. Therefore, institutional policies prevent us from publicly releasing our data tables and their annotations, but, within the data sharing regulations of our institution, we have attempted to provide meaningful information on the content and formatting of our outputs throughout this manuscript. We are committed to open-source science and to ensuring the reproducibility of the research we present here; therefore, we are happy to discuss data transfer requests with researchers interested in our results. Interested investigators should contact the Corresponding Authors at the addresses accompanying this manuscript, and they are happy to discuss forwarding such requests to OCM.
